The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Exactly. Eventually 2,000,000 capacity per week.
The recently CE marked Mologic antibody test is said to provide a margin of circa £1.80. Whilst the RTC test sells for £13 but an exact margin to ODX is yet to be finalised. We await info on the antigen LFT’s.
But yep, precisely, WOW.
Aha - ok - i mis translated that part - OK thanks - and even better news. Wow this could really blow this out of the water and as per my previous point - none of this takes into account possible shirt extensions or O/T
So a simple WOW
Per the Fincapp report they were looking at an additional facility in Dundee. Sop there must be another delivery of machines expected for the new site. It was £1.1m to get to £500k and then another £1.9m to get to 1m, so that must be just a third of the investment in that twitter picture.
But we are not in negotiations or conversations with BioDot to buy more machines (yet)
Or are we?
This comment was in the Fundraise prospectus, confirming that a formal agreement will be in palce before the expiry of the MOU.
"The MOU is for an initial period of six months, during which the parties committed to setting a time limit for post-MOU negotiations. Under the MOU, the Parties agreed to collaborate to utilise their combined lateral flow test design and manufacturing expertise to optimise the design for potential accelerated scale-up to manufacturing of the COVID-19 Rapid Test"
They have done their very best to spell it out in all the communications from Omega and those of the consortium. It is clear as it can be.
This is not something that might happen, this is already happening. They are already in production for mass testing.
https://www.biodot.com/abingdon-health-antibody-test-manufacturing/
Where did that information come from? Ive seen nothing official and the fact the capacity has gone from 100k to 200k to 400k to now 500K is pretty impressive in itself - Id imagine theyd extend to night shifts before they invest in more capital equipment ?
Seems like a positive sign that ODX are talking to Biodot about more machines.